0001070081-20-000013.txt : 20200108
0001070081-20-000013.hdr.sgml : 20200108
20200108180741
ACCESSION NUMBER: 0001070081-20-000013
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200106
FILED AS OF DATE: 20200108
DATE AS OF CHANGE: 20200108
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Utter Christine Marie
CENTRAL INDEX KEY: 0001707685
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35969
FILM NUMBER: 20516671
MAIL ADDRESS:
STREET 1: C/O PTC THERAPEUTICS, INC.
STREET 2: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001070081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043416587
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
BUSINESS PHONE: 9082227000
MAIL ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
FORMER COMPANY:
FORMER CONFORMED NAME: PTC THERAPEUTICS INC
DATE OF NAME CHANGE: 19980909
4
1
wf-form4_157852483759758.xml
FORM 4
X0306
4
2020-01-06
0
0001070081
PTC THERAPEUTICS, INC.
PTCT
0001707685
Utter Christine Marie
C/O PTC THERAPEUTICS, INC.
100 CORPORATE COURT
SOUTH PLAINFIELD
NJ
07080
0
1
0
0
SVP, Finance & CAO
Common Stock
2020-01-06
4
S
0
360
48.168
D
5224
D
Common Stock
2020-01-07
4
M
0
6250
13.10
A
11474
D
Common Stock
2020-01-07
4
S
0
6250
50
D
5224
D
Common Stock
2020-01-07
4
M
0
7500
18.01
A
12724
D
Common Stock
2020-01-07
4
S
0
7500
50.031
D
5224
D
Stock Option (Right To Buy)
13.1
2020-01-07
4
M
0
6250
13.10
D
2027-06-02
Common Stock
6250.0
0
D
Stock Option (Right To Buy)
18.01
2020-01-07
4
M
0
7500
18.01
D
2028-01-02
Common Stock
7500.0
22500
D
Stock Option (Right To Buy)
490.8
2021-04-27
Common Stock
74.0
74
D
Stock Option (Right To Buy)
218.4
2022-01-10
Common Stock
21.0
21
D
Stock Option (Right To Buy)
40.45
2024-09-23
Common Stock
4688.0
4688
D
Stock Option (Right To Buy)
51.0
2025-01-02
Common Stock
17800.0
17800
D
Stock Option (Right To Buy)
30.86
2026-01-03
Common Stock
10310.0
10310
D
Stock Option (Right To Buy)
11.23
2027-01-02
Common Stock
3150.0
3150
D
Stock Option (Right To Buy)
33.02
2029-01-21
Common Stock
42500.0
42500
D
Stock Option (Right To Buy)
33.02
2029-01-21
Common Stock
10100.0
10100
D
Represents shares automatically sold pursuant to an irrevocable sell to cover election to satisfy tax withholding obligations in connection with the vesting of 975 RSUs from a January 3, 2017 grant of 3,900 RSUs.
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 29, 2019.
This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $50.00 to $50.09 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
Currently exercisable.
This option was granted on January 3, 2018, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2019, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2019.
This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.
This option was granted on January 22, 2019 and vests over four years, with 25% of the shares underlying the option vesting on January 22, 2020, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning April 22, 2020.
This option was granted on January 22, 2019 and vests over four years, with 50% of the shares underlying the option vesting on January 22, 2022, and the remaining 50% of the original number of shares underlying the option vesting on January 22, 2023.
/s/ Avraham S. Adler, attorney-in-fact
2020-01-08